{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:07:35Z","timestamp":1760234855932,"version":"build-2065373602"},"reference-count":63,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Primary sclerosing cholangitis (PSC) is a rare cholestatic disease of the liver of unknown etiology, severe course and poor prognosis. PSC most often co-occurs with inflammatory bowel diseases (IBD), especially with ulcerative colitis (UC). The aim of the study was the analysis of the clinical course of primary sclerosing cholangitis in children, hospitalized in the Gastroenterology Unit in Katowice. Materials and Methods: The analysis included 30 patients, aged from 7 to 18 years, 21\/30 boys (70%) and 9\/30 girls (30%), diagnosed with PSC in the years 2009\u20132019. The analysis included the age at diagnosis, clinical symptoms, course of the disease, coexisting diseases, laboratory and imaging results, and complications. Results: The average age at diagnosis was 13 years. 22\/30 (73.3%) patients suffered from UC, 4\/30 (13.3%) were diagnosed with Crohn\u2019s disease (CD), 2\/30 (6.66%) with Eosinophilic Colitis (EC). 2\/30 patients (6.66%) had no clinical evidence of coexistent IBD to date. In addition, 7\/30 (23.3%) had an overlap syndrome of primary sclerosing cholangitis\/autoimmune hepatitis. When PSC was detected before IBD (6\/30\u201320%), patients had complications more often compared to those diagnosed with IBD first or PSC and IBD at the same time. At the moment of diagnosis 6\/30 (20%) patients presented with abdominal pain, which was the most common symptom, 3\/30 (10%) jaundice, while 17\/30 (56.6%) were asymptomatic but had abnormal results of the laboratory tests. Conclusions: Monitoring liver markers in IBD patients is important since most PSC cases are asymptomatic and their elevation might be the first sign of the disease. Patients diagnosed with PSC before IBD diagnosis are more likely to have a more aggressive course of the disease.<\/jats:p>","DOI":"10.3390\/medicina57070663","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T23:57:22Z","timestamp":1624838242000},"page":"663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population\u2014Single Center Study"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9870-6674","authenticated-orcid":false,"given":"Sabina","family":"Wiecek","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Faculty of Medical Sciences, Medical University of Silesia, 16 Medykow Street, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-3011","authenticated-orcid":false,"given":"Alicja","family":"Wojtyniak","sequence":"additional","affiliation":[{"name":"Student Scientific Club, Department of Paediatrics, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-8432","authenticated-orcid":false,"given":"Barbara","family":"Pindur","sequence":"additional","affiliation":[{"name":"Student Scientific Club, Department of Paediatrics, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-5899","authenticated-orcid":false,"given":"Magdalena","family":"Machnikowska-Soko\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Gruszczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Grzybowska-Chlebowczyk","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculty of Medical Sciences, Medical University of Silesia, 16 Medykow Street, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(00)80377-3","article-title":"Regulation and deregulation of cholangiocyte proliferation","volume":"33","author":"Alvaro","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: A multi-center, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/s0004-2803.201700000-50","article-title":"Primary Sclerosing Cholangitis in Children and Adolescents","volume":"54","author":"Fagundes","year":"2017","journal-title":"Arq. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: A long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/17474124.2018.1521719","article-title":"Lindor Primary sclerosing cholangitis in children versus adults: Lessons for the clinic","volume":"12","author":"Abimbola","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"Janse","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_9","first-page":"124","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: An update of the evidence","volume":"32","author":"Mertz","year":"2019","journal-title":"Ann. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2015.06.018","article-title":"Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis","volume":"63","author":"Carpino","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep.23564","article-title":"The utility of genome-wide association studies in hepatology","volume":"51","author":"Karlsen","year":"2010","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pr. Res. Clin. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00042737-199907000-00015","article-title":"Immunohistochemical analysis of inflammation in primary sclerosing cholangitis","volume":"11","author":"Ponsioen","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.1840050321","article-title":"Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis","volume":"5","author":"Whiteside","year":"1985","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J. Crohn Coliti"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"386.1","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC\u2013IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep4.1251","article-title":"Gamma Glutamyltransferase Reduction Is Associated with Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis","volume":"2","author":"Deneau","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_22","unstructured":"Jankowska, I. (2018). Pierwotne stwardniaj\u0105ce zapalenie dr\u00f3g \u017c\u00f3\u0142ciowych. Pediatria I. Redakcja naukowa Wanda Kawalec, Ryszard Grenda, Marek Kulus, PZWL Wydawnictwo Lekarskie."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in the liver stiffness measured by transient elas-tography are associated with severity of fibrosis and outcome of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-009-0006-6","article-title":"Small -duct primary sclerosing cholangitis","volume":"11","author":"Bjimsson","year":"2009","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: Epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/liv.12492","article-title":"Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease","volume":"34","author":"Naess","year":"2014","journal-title":"Liver Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN Hepatology Committee position statement","volume":"66","author":"Vergani","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11894-018-0649-2","article-title":"Post-Transplant Disease Recurrence in Pediatric PSC","volume":"20","author":"Soufi","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001368","article-title":"The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study","volume":"63","author":"Valentino","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4254\/wjh.v11.i1.19","article-title":"Treatment of primary sclerosing cholangitis in children","volume":"11","author":"Laborda","year":"2019","journal-title":"World J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: Primary Sclerosing Cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.dld.2019.04.011","article-title":"Eosinophilic colitis: A clinical review","volume":"51","author":"Impellizzeri","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000445259","article-title":"Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?","volume":"1","author":"Tanaka","year":"2016","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0031-1291540","article-title":"What an endoscopist should know about immunoglobulin -G4-associated disease of the pancreas and biliary tree","volume":"44","author":"Maillette","year":"2012","journal-title":"Endoscopy"},{"key":"ref_40","first-page":"26","article-title":"Primary sclerosing cholangitis","volume":"64","author":"Olson","year":"1965","journal-title":"Northwest Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1478-3231.1999.tb00040.x","article-title":"Primary sclerosing cholangitis (PSC): Clinical, laboratory and survival analysis in children and adults","volume":"19","author":"Floreanl","year":"1999","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldv019","article-title":"Primary sclerosing cholangitis: A clinical update","volume":"114","author":"Williamson","year":"2015","journal-title":"Br. Med Bull."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cgh.2019.08.048","article-title":"Primary Sclerosing Cholangitis in Children with Inflammatory Bowel Diseases Is Associated with Milder Clinical Activity but More Frequent Subclinical Inflammation and Growth Impairment","volume":"18","author":"Ricciuto","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Stinton, L.M., Bentow, C., Mahler, M., Norman, G.L., Eksteen, B., Mason, A., Kaplan, G., Lindkvist, B., Hirschfield, G., and Milkiewicz, P. (2014). PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112877"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpeds.2019.07.065","article-title":"Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels","volume":"215","author":"Chandrakumar","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.pathol.2019.07.002","article-title":"The significance of ANCA positivity in patients with inflammatory bowel disease","volume":"51","author":"Lee","year":"2019","journal-title":"Pathology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejrnm.2011.09.007","article-title":"Primary sclerosing cholangitis: Evaluation with MR cholangiopancreatography (MRCP)","volume":"42","author":"Eid","year":"2011","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_48","unstructured":"Al-Dhuhli (2009). Role of magnetic resonance cholangiopancreatography in the evaluation of biliary disease. SQU Med. J., 9, 341\u2013353."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/sjg.SJG_478_18","article-title":"The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review","volume":"25","author":"Segal","year":"2019","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000440823","article-title":"Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis","volume":"33","author":"Ponsioen","year":"2015","journal-title":"Dig. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0033-8389(02)00046-5","article-title":"MR cholangiopancreatography","volume":"40","author":"Fulcher","year":"2002","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1148\/radiographics.20.4.g00jl04959","article-title":"Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopan-creatography","volume":"20","author":"Vitellas","year":"2000","journal-title":"Radiographics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A Retrospective Single-Center Review of Primary Sclerosing Cholangitis in Children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cld.251","article-title":"Primary sclerosing cholangitis during childhood and adolescence","volume":"2","author":"Miloh","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenosis in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: Outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenosis and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolf","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J. Gastrointest. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.clinre.2011.04.007","article-title":"Current consensus on the management of primary sclerosing cholangitis","volume":"35","author":"Wiencke","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/7\/663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:25:22Z","timestamp":1760163922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/7\/663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["medicina57070663"],"URL":"https:\/\/doi.org\/10.3390\/medicina57070663","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2021,6,27]]}}}